1. Advanced design and development of nanoparticle/microparticle dual-drug combination lactose carrier-free dry powder inhalation aerosols. Issue 68 (17th November 2020) Authors: Muralidharan, Priya; Mallory, Evan K.; Malapit, Monica; Phan, Hanna; Ledford, Julie G.; Hayes, Don; Mansour, Heidi M. Journal: RSC advances Issue: Volume 10:Issue 68(2020) Page Start: 41846 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Advanced spray dried proliposomes of amphotericin B lung surfactant-mimic phospholipid microparticles/nanoparticles as dry powder inhalers for targeted pulmonary drug delivery. (October 2020) Authors: Gomez, Alexan I.; Acosta, Maria F.; Muralidharan, Priya; Yuan, Jason X.-J; Black, Stephen M.; Hayes, Don; Mansour, Heidi M. Journal: Pulmonary pharmacology & therapeutics Issue: Volume 64(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy. (March 2021) Authors: Acosta, Maria F.; Muralidharan, Priya; Grijalva, Carissa L.; Abrahamson, Michael D.; Hayes, Don; Fineman, Jeffrey R.; Black, Stephen M.; Mansour, Heidi M. Journal: Therapeutic advances in respiratory disease Issue: Volume 15(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Dry powder inhalers in COPD, lung inflammation and pulmonary infections. (June 2014) Authors: Muralidharan, Priya; Hayes, Don; Mansour, Heidi M Journal: Expert opinion on drug delivery Issue: Volume 12:Number 6(2015:Jun.) Page Start: 947 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Dry powder inhalers in COPD, lung inflammation and pulmonary infections. (June 2014) Authors: Muralidharan, Priya; Hayes, Don; Mansour, Heidi M Journal: Expert opinion on drug delivery Issue: Volume 12:Number 6(2015:Jun.) Page Start: 947 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Microparticulate/nanoparticulate powders of a novel Nrf2 activator and an aerosol performance enhancer for pulmonary delivery targeting the lung Nrf2/Keap-1 pathway. Issue 1 (27th January 2016) Authors: Muralidharan, Priya; Hayes, Don; Black, Stephen M.; Mansour, Heidi M. Journal: Molecular Systems Design and Engineering Issue: Volume 1:Issue 1(2016) Page Start: 48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Modelling COVID-19 supply chain disruption and recovery: A case study from the e-commerce industry. Issue 10 (2022) Authors: Muralidharan, Priya; Hargaden, Vincent; Ghadimi, Pezhman Journal: IFAC-PapersOnLine Issue: Volume 55:Issue 10(2022) Page Start: 317 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗